- Home
- SLVM vs XENE Comparison
SLVM vs XENE Comparison
Compare SLVM & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLVM
- XENE
- Stock Information
- Founded
- SLVM 1898
- XENE 1996
- Country
- SLVM United States
- XENE Canada
- Employees
- SLVM N/A
- XENE N/A
- Industry
- SLVM Paper
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SLVM Basic Materials
- XENE Health Care
- Exchange
- SLVM Nasdaq
- XENE Nasdaq
- Market Cap
- SLVM 3.5B
- XENE 3.3B
- IPO Year
- SLVM N/A
- XENE 2014
- Fundamental
- Price
- SLVM $78.14
- XENE $38.52
- Analyst Decision
- SLVM Hold
- XENE Strong Buy
- Analyst Count
- SLVM 3
- XENE 7
- Target Price
- SLVM $89.00
- XENE $56.00
- AVG Volume (30 Days)
- SLVM 457.3K
- XENE 424.9K
- Earning Date
- SLVM 02-12-2025
- XENE 02-27-2025
- Dividend Yield
- SLVM 2.30%
- XENE N/A
- EPS Growth
- SLVM N/A
- XENE N/A
- EPS
- SLVM 6.41
- XENE N/A
- Revenue
- SLVM $3,767,000,000.00
- XENE N/A
- Revenue This Year
- SLVM $3.31
- XENE N/A
- Revenue Next Year
- SLVM N/A
- XENE $1,600.08
- P/E Ratio
- SLVM $12.19
- XENE N/A
- Revenue Growth
- SLVM 2.25
- XENE N/A
- 52 Week Low
- SLVM $44.94
- XENE $35.53
- 52 Week High
- SLVM $98.02
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- SLVM 41.44
- XENE 42.98
- Support Level
- SLVM $73.68
- XENE $36.90
- Resistance Level
- SLVM $81.77
- XENE $41.03
- Average True Range (ATR)
- SLVM 2.43
- XENE 1.41
- MACD
- SLVM 0.31
- XENE 0.03
- Stochastic Oscillator
- SLVM 55.13
- XENE 30.39
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.